DEF 14A

Company

Cardiff Oncology, Inc.

Filed

July 23, 2014

Period of Report

September 17, 2014

Accession Number

0001104659-14-052781

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →